Search results
Oct 20, 2020 · View Lisa Johnson-Pratt, MD’s profile on LinkedIn, a professional community of 1 billion members. *Physician and Pharmaceutical Executive committed to making the world better for…
- 500+
- Aspen Neuroscience, Inc.
- 1.5K
Feb 14, 2024 · An industry leader with more than 25 years of experience, Dr. Johnson-Pratt will guide therapeutic development for ANPD001, the first autologous neuron replacement to treat Parkinson’s disease (PD), and new product strategy for Aspen.
lisa johnson-pratt, md Senior Vice President, Therapeutic Program Lead An industry leader with more than 25 years of experience, Dr. Johnson-Pratt is a senior drug development, clinical and commercial expert.
Feb 14, 2024 · SAN DIEGO, Feb. 14, 2024 /PRNewswire/ — Aspen Neuroscience, Inc., a private biotechnology company developing induced Pluripotent Stem Cell (iPSC)-derived cell therapies, announced that Lisa Johnson-Pratt, MD has joined the company’s executive management team in a new role as Senior Vice…
Lisa Johnson-Pratt, MD. Director. Dr. Johnson-Pratt joined as a director in 2021. In September 2019, Dr. Johnson-Pratt founded Ananias Ventures and has served as Biotechnology, Cell and Gene Therapy Strategic Commercial Advisor there since June 2022.
May 24, 2021 · Dr. Johnson-Pratt currently serves as senior vice president, new product commercial strategy at Ionis Pharmaceuticals, a leading innovator in RNA-targeted therapeutics.
Feb 14, 2024 · Aspen Neuroscience, Inc., a private biotechnology company developing induced Pluripotent Stem Cell (iPSC)-derived cell therapies, announced that Lisa Johnson-Pratt, MD has joined the company's...